A new report says pharmaceutical sales growth has slowed in mature markets like the U.S. and Western Europe while it’s set to grow in China and Brazil. And it says unless current leading drug makers quickly expand into those markets, they’ll cede them to local producers. Law Professor Kevin Outterson, an authority on drup patents and marketing, says Big Pharma better catch up.
“Drug companies can no longer view these markets as marginal, nor ignore the people priced out of the market in these countries due to poverty.”
Contact Kevin Outterson, 617-353-3103, email@example.com